Diabetes is a public health crisis, and diabetes-related health and economic burdens have
been rising globally over the past decades, with the growth being the most striking in low …

Abstract α-Amylase play important role in hydrolyses of α-bonds of large α-linked
polysaccharides; thus, it is a potential drug target in diabetes mellites (DM) and its inhibition …

Background: While evidence supports glycemic control benefits for individuals with type 1
diabetes mellitus (T1DM) using hybrid closed-loop (HCL) systems, HCL automated insulin …

The discovery and subsequent introduction of insulin therapy in 1922 led to fundamental
changes in the treatment and epidemiology of type 1 diabetes. In Boston, MA, USA, the life …

Following the seminal discovery of insulin a century ago, treatment of individuals with type 1
diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose …

Background Type 1 diabetes can occur at any age. The majority of literature on type 1
diabetes were reported in children whereas adult-onset type 1 diabetes is less well …

Type 1 diabetes (T1D) is a polygenic disease and does not follow a mendelian pattern.
Inborn errors of immunity (IEIs), on the other hand, are caused by damaging germline …

Aims This study aimed to investigate the correlation of the fat‐to‐muscle ratio (FMR) with
insulin resistance (IR) and cardiometabolic disorders (CMD) in patients with type 1 diabetes …

ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune endocrinopathy
with increasing incidence that results in the depletion of pancreatic beta cells and …

BACKGROUND: Type 1 diabetes (T1D) is a major cause of endothelial dysfunction.
Although cellular bioenergetics has been identified as a new regulator of vascular function …